Detalhe da pesquisa
1.
Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry.
J Crohns Colitis
; 18(1): 65-74, 2024 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37522878
2.
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry.
Therap Adv Gastroenterol
; 17: 17562848231221713, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38187926
3.
Risk of rebleeding, vascular events and death after gastrointestinal bleeding in anticoagulant and/or antiplatelet users.
Aliment Pharmacol Ther
; 50(8): 919-929, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31486121
4.
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.
J Crohns Colitis
; 13(12): 1492-1500, 2019 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31063540
5.
Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry.
Aliment Pharmacol Ther
; 48(8): 839-851, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30281832
6.
Controversias en la intolerancia al trigo no celíaca / No disponible
Gastroenterol. hepatol. (Ed. impr.)
; 41(supl.esp.3): 1-5, nov. 2018. graf
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-180583